YourHealthRx Tirzepatide Review: Cost, No Titration Penalty & Honest Verdict (2026)

YourHealthRx is a scientist-founded peptide and GLP-1 telehealth platform available in all 50 states and DC via a multi-state (IMLC) clinician network. Every fact here comes from the company's own published program.

What YourHealthRx is

YourHealthRx offers compounded semaglutide and tirzepatide in two formats — weekly injectable (with B12) or a daily oral dissolving tablet. It's science-forward and clinician-led, with built-in follow-up, lab testing, and a broad peptide and longevity catalog (BPC-157, TB-500, sermorelin, NAD+).

What YourHealthRx costs

The flat subscription price doesn't change as your dose increases — no titration penalty. However, the headline price is a first-month intro rate; the ongoing monthly cost runs higher, roughly $170/month for semaglutide and $210/month for tirzepatide.

The brand-vs-compounded question

YourHealthRx dispenses compounded semaglutide and tirzepatide only — not brand Wegovy, Ozempic, Zepbound, or Mounjaro. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

YourHealthRx's real strengths: all-50-states-plus-DC coverage through a licensed multi-state clinician network, no titration penalty, a broad peptide and longevity catalog, and transparent, education-first positioning with published legal pages. The trade-offs: the headline price is a first-month intro rate, not the ongoing cost, the compounding pharmacy partner isn't named despite a "transparent sourcing" claim, no LegitScript certification is displayed, and YourHealthRx is the platform, not the prescriber or pharmacy — eligibility runs through partner clinical workflows. As with any GLP-1 program, confirm your ongoing monthly rate, not just the intro price, before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

YourHealthRx's no-titration-penalty pricing and broad peptide catalog are genuine positives, but confirm the ongoing monthly cost, not the first-month intro rate, before signing up. For a provider with fully transparent standing pricing, compare it against Vitara RX or Zera Health. See our best tirzepatide providers ranking for the full field.